Medication info
Beatorin Tablets 10/20

Beatorin Tablets 10/20

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›20mg / 1 tablet
Manufacturer / importer
Daewoong Bio Co., Ltd.
Appearance
White to off-white, double-convex, rectangular tablet
Packaging
30 tablets (10 tablets/PTPX3)
Approval status
Active

MFDS item code 201601144 · Approved 2016.02.29 · Insurance code 694001010

Summary

Main use
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. Administer once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dosage range is 10/10mg to 10/40mg once daily. The usual recommended starting dose is 10/20mg once daily. Patients who require less LDL cholesterol reduction may start with 10/10mg once daily. Check blood lipid levels at least 4 weeks after starting treatment or adjusting the dose, and then adjust the dose accordingly. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not available. Administration in patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function under Precautions for Use). Administration in patients with renal impairment and patients with chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. If higher doses are administered to these patients, use caution and monitor them closely (see 5. General Precautions under Precautions for Use). Administration in older adults No dose adjustment is necessary in older adults. Concomitant administration with other medicines (See 6. Interactions under Precautions for Use.) Administer this medicine at least 2 hours before or 4 hours after a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Ingredients

Manufacturer
Daewoong Bio Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular disease due to hypercholesterolemia
View approved original text

This medicine helps to lower elevated total cholesterol, LDL-cholesterol, apoB protein, and triglycerides in patients with primary hypercholesterolemia, particularly heterozygous familial and non-familial hypercholesterolemia, and raises HDL-cholesterol levels. It is additionally used in homozygous familial hypercholesterolemia patients when other treatments are ineffective or used in combination with other treatments. This drug is indicated for patients who do not respond adequately to appropriate dietary changes and non-drug therapy, and it is important to confirm and treat secondary causes such as diabetes and hypothyroidism before administration. During treatment, lipid values such as total cholesterol, LDL, HDL, and triglycerides should be monitored regularly, considering risk factors carefully. This drug is used to reduce the risk of cardiovascular disease and improve dyslipidemia.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. Administer once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dosage range is 10/10mg to 10/40mg once daily. The usual recommended starting dose is 10/20mg once daily. Patients who require less LDL cholesterol reduction may start with 10/10mg once daily. Check blood lipid levels at least 4 weeks after starting treatment or adjusting the dose, and then adjust the dose accordingly. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not available. Administration in patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function under Precautions for Use). Administration in patients with renal impairment and patients with chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. If higher doses are administered to these patients, use caution and monitor them closely (see 5. General Precautions under Precautions for Use). Administration in older adults No dose adjustment is necessary in older adults. Concomitant administration with other medicines (See 6. Interactions under Precautions for Use.) Administer this medicine at least 2 hours before or 4 hours after a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Precautions

This drug may cause muscle-related side effects such as myopathy and rhabdomyolysis, so consult a doctor immediately if symptoms of muscle pain or weakness occur. Additionally, this drug should not be administered to patients with hypersensitivity to its components, those with active liver disease, or pregnant or breastfeeding women. This drug may affect liver function, so patients with a history of liver disease or abnormal liver function tests should use it with caution. Particularly, elderly patients, those with hypothyroidism, and renal impairment are at higher risk for muscle disorders and require closer observation. This drug may interact with other medications, so inform your doctor or pharmacist about any current medications you are taking. Specifically, concurrent use with certain antifungal agents, antibiotics, immunosuppressants, calcium channel blockers, and fibrate drugs may increase the risk of muscle-related side effects. It is advisable to avoid certain foods like grapefruit juice while taking this drug, and regular blood tests to monitor liver function and muscle enzyme levels are recommended. Women who are planning to become pregnant or who are potentially pregnant should consult a doctor before taking this medicine, and if pregnancy is confirmed, they should stop taking it immediately. It is also recommended to avoid taking this drug while breastfeeding, and if necessary, cease breastfeeding for safety. Caution is warranted as the safety and efficacy have not been adequately established in children and adolescents. In case of overdose, as there is no specific antidote, appropriate treatment should be received immediately at a hospital.

Side effects

  • Myopathy
  • rhabdomyolysis
  • increased creatine kinase
  • headache
  • diarrhea
  • influenza
  • upper respiratory infection
  • myalgia
  • limb pain
  • fatigue
Show 103 more
  • abdominal pain
  • viral infection
  • pharyngitis
  • sinusitis
  • arthralgia
  • low back pain
  • cough
  • anaphylaxis
  • urticaria
  • rash
  • angioedema
  • elevated liver aminotransferase levels
  • hepatitis
  • thrombocytopenia
  • nausea
  • pancreatitis
  • dizziness
  • sensory disturbances
  • depression
  • cholelithiasis
  • cholecystitis
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • eosinophilia
  • drug reactions with systemic symptoms
  • polymorphic erythema
  • liver damage
  • myasthenia
  • cataract
  • constipation
  • dyspepsia
  • flatulence
  • nausea
  • eczema
  • pruritus
  • rash
  • muscle cramps
  • specific cranial nerve dysfunction
  • oculomotor dysfunction
  • facial incomplete paralysis
  • tremor
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorders
  • anxiety
  • sleep disorders
  • memory impairment
  • amnesia
  • forgetfulness
  • memory loss
  • confusion
  • interstitial lung disease
  • lupus erythematosus-like syndrome
  • polymyositis
  • dermatomyositis
  • vasculitis
  • purpura
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibodies
  • increased erythrocyte sedimentation rate
  • arthritis
  • fever
  • chills
  • flushing
  • malaise
  • dyspnea
  • cholestasis jaundice
  • hepatic steatosis
  • cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • liver failure
  • loss of appetite
  • vomiting
  • alopecia
  • various skin changes
  • lichenoid drug rash
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • ocular muscle paralysis
  • anemia
  • elevated aminotransferases
  • elevated ALP
  • elevated gamma-GT
  • increased bilirubin level
  • thyroid dysfunction
  • increased HbA1c
  • increased fasting blood glucose levels
  • edema
  • thirst
  • facial swelling
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucous stools
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This drug is sensitive to air and moisture, so it must be stored in a tightly sealed container. Additionally, it should be kept at room temperature between 1 to 30 degrees Celsius, avoiding excessively hot or cold locations.

Appearance and packaging

Appearance

White to off-white, double-convex, rectangular tablet

Package unit

30 tablets (10 tablets/PTPX3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.